Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF‐κB
Open Access
- 14 June 2010
- journal article
- Published by Wiley in Cancer Science
- Vol. 101 (7) , 1590-1595
Abstract
Cholangiocarcinoma (CCA) is a major cause of cancer deaths in northeast Thailand. It is aggressive, highly metastatic, and responds poorly to traditional chemotherapy. We demonstrated the potential for Cepharanthine (CEP), a biscoclaurine alkaloid extracted from Stephania cepharantha, to treat CCA. CEP significantly inhibited growth of human CCA cell lines in a dose‐ and time‐dependent manner, regardless of the histologic type of tumor origin. Increasing cell apoptosis via caspase‐3 and capase‐9 activation was demonstrated in CEP‐treated cells. We found that CEP controlled the growth of CCA cells through nuclear factor‐kappa B (NF‐κB) inactivation by inhibiting nuclear translocation. CEP treatment effectively reduced tumor size in CCA‐inoculated mice without serious side effects. CEP also increased cell apoptosis in primary histocultures of CCA patients’ tissues; this was demonstrated by immunohistochemistry using TUNEL staining. Our results suggest that CEP possesses therapeutic potential against human CCA. (Cancer Sci 2010)Keywords
This publication has 22 references indexed in Scilit:
- Cytotoxic activity of alkaloids isolated from Stephania rotunda in vitro cytotoxic activity of cepharanthinePhytotherapy Research, 2008
- Early development of human hematopoietic and acquired immune systems in new born NOD/Scid/Jak3null mice intrahepatic engrafted with cord blood-derived CD34+ cellsInternational Journal of Hematology, 2008
- The effects of biscoclaurine alkaloid cepharanthine on mammalian cells: Implications for cancer, shock, and inflammatory diseasesLife Sciences, 2007
- Comparison of gene expression profiles between Opisthorchis viverrini and non‐Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma†Hepatology, 2006
- Cepharanthine triggers apoptosis in a human hepatocellular carcinoma cell line (HuH‐7) through the activation of JNK1/2 and the downregulation of AktFEBS Letters, 2005
- Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing CholangitisAmerican Journal of Gastroenterology, 2004
- Diagnosis and Treatment of CholangiocarcinomaThe Oncologist, 2004
- Cholangiocarcinoma: Current Concepts and InsightsHepatology, 2003
- Modes of activation of mitogen-activated protein kinases and their roles in cepharanthine-induced apoptosis in human leukemia cellsCellular Signalling, 2002
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970